Astrazeneca’s Baxfendy wins US approval as first-in-class hypertension drug
Baxfendy works in a fundamentally different way from current therapies
Baxfendy works in a fundamentally different way from current therapies
The initiative by Rheumatology Association of Gujarat is aimed at strengthening patient-centric autoimmune care
The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy
Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses
Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
The approval was driven by data from the Phase III TULIP-SC trial
Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control
Aims to boost speed & precision in patient care
Subscribe To Our Newsletter & Stay Updated